The aortic valve microenvironment and its role in calcific aortic valve disease

被引:84
作者
Yip, Cindy Ying Yin [2 ]
Simmons, Craig A. [1 ,2 ,3 ]
机构
[1] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada
[2] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G8, Canada
[3] Univ Toronto, Fac Dent, Toronto, ON M5S 3G8, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Aortic sclerosis; Aortic stenosis; Mechanobiology; Calcification; Biomechanics; MATRIX-METALLOPROTEINASE EXPRESSION; INTERSTITIAL CELL CALCIFICATION; FACTOR-KAPPA-B; TRANSFORMING GROWTH-FACTOR-BETA-1; MORPHOGENETIC PROTEIN-2; MECHANICAL-PROPERTIES; RECEPTOR ACTIVATOR; EARLY LESION; MYOFIBROBLASTS; STENOSIS;
D O I
10.1016/j.carpath.2010.12.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In calcific aortic valve disease, fibrotic and calcific lesions form focally in the fibrosa layer of the valve leaflets. Layer-specific pathosusceptibility suggests that the fibrosa microenvironment is permissive to pathological development. The cellular microenvironment in the aortic valve is defined by a variety of biomechanical-, biochemical-, and extracellular-mediated factors, some of which are unique to the fibrosa. Growing evidence supports the role of these microenvironmental cues in the local regulation of side-specific valve cell phenotypes and focal pathological alterations, revealing new insights into the cellular and molecular processes that contribute to calcific aortic valve disease. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 50 条
  • [21] Health Behaviors and Calcific Aortic Valve Disease
    Lamprea-Montealegre, Julio A.
    Otto, Catherine M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (03):
  • [22] Molecular imaging of calcific aortic valve disease
    Jae-Joon Jung
    Farid Jadbabaie
    Mehran M. Sadeghi
    Journal of Nuclear Cardiology, 2018, 25 : 1148 - 1155
  • [23] Role of Runx2 in Calcific Aortic Valve Disease in Mouse Models
    Dharmarajan, Subramanian
    Speer, Mei Y.
    Pierce, Kate
    Lally, Jake
    Leaf, Elizabeth M.
    Lin, Mu-En
    Scatena, Marta
    Giachelli, Cecilia M.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [24] Introduction to the Compendium on Calcific Aortic Valve Disease
    Heistad, Donald D.
    Shanahan, Catherine
    Demer, Linda L.
    CIRCULATION RESEARCH, 2013, 113 (02) : 176 - 178
  • [25] Lipoprotein(a) and calcific aortic valve disease: current evidence and future directions
    Lan, Nick S. R.
    Khan, Zahid
    Watts, Gerald F.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2024, 27 (01) : 77 - 86
  • [26] Computational assessment of bicuspid aortic valve wall-shear stress: implications for calcific aortic valve disease
    Chandra, Santanu
    Rajamannan, Nalini M.
    Sucosky, Philippe
    BIOMECHANICS AND MODELING IN MECHANOBIOLOGY, 2012, 11 (07) : 1085 - 1096
  • [27] Calcific aortic valve disease and cardiometabolic triggers: an explanation behind progression of aortic valvular disease and failure of medical therapy interventions
    Prabhakar, Akruti Patel
    Lopez-Candales, Angel
    POSTGRADUATE MEDICINE, 2024, 136 (08) : 810 - 818
  • [28] Bicuspid Aortic Valve Hemodynamic Abnormalities Promote Early Development of Calcific Aortic Valve Disease
    Sun, Ling
    Chandra, Santanu
    Sucosky, Philippe
    CIRCULATION RESEARCH, 2012, 111 (04)
  • [29] Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets
    Hulin, Alexia
    Hego, Alexandre
    Lancellotti, Patrizio
    Oury, Cecile
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2018, 5
  • [30] Role for Galectin-3 in Calcific Aortic Valve Stenosis
    Rafael Sadaba, J.
    Martinez-Martinez, Ernesto
    Arrieta, Vanessa
    Alvarez, Virginia
    Fernandez-Celis, Amaya
    Ibarrola, Jaime
    Melero, Amaia
    Rossignol, Patrick
    Cachofeiro, Victoria
    Lopez-Andres, Natalia
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (11):